Single Ascending Dose, Multiple Ascending Dose, Food Effect Study

NCT06938204 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Innovo Therapeutics, Inc.